Hello, Guest
Login
Sign Up
 
 

Stocks Review: Chevron Corporation, Abbott Laboratories , Macy's, Inc. , Sanofi SA (ADR)

 
 
Repost This

Lakeway, TX -- (SBWIRE) -- 03/22/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Chevron Corporation (NYSE:CVX) fell 0.01% and trading at $120.34. Chevron Corporation (Chevron) manages its investments in subsidiaries and affiliates and provides administrative, financial, management and technology support to the United States and international subsidiaries that engage in petroleum operations, chemicals operations, mining operations, power generation and energy services.

How Should Investors Trade CVX After The Recent Movement? Find Out Here

Abbott Laboratories (NYSE:ABT) lost 0.98% and trading at $33.48Abbott Laboratories (Abbott), is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products. Abbott operates in four business segments: diagnostics, medical devices, nutritionals and generic pharmaceuticals.

Is ABT Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Macy's, Inc. (NYSE:M) lost 0.59% and trading at $42.17. Macy’s, Inc. (Macy’s) is a retail organization operating stores and Internet Websites under two brands (Macy's and Bloomingdale's) that sell a range of merchandise, including apparel and accessories (men's, women's and children's), cosmetics, home furnishings and other consumer goods in 45 states, the District of Columbia, Guam and Puerto Rico.

Is M a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Sanofi SA (ADR) (NYSE:SNY) went down 1.52% and trading at $49.96. Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. Sanofi has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products.

How Should Investors Trade SNY After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.